Duloxetine Delayed-Release Capsules: recall status
⚠ Recalls found. Duloxetine Delayed-Release Capsules is named in 2 official recalls in our current data:
- Brand
- Breckenridge Pharmaceutical
Recalls naming this model
FDA Class II · Drug · June 17, 2026
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Company / brand: Breckenridge Pharmaceutical
Affected product: Duloxetine Delayed-Release Capsules
Official ID D-0582-2026 ·
Official record ↗
FDA Class II · Drug · June 17, 2026
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Company / brand: Breckenridge Pharmaceutical
Affected product: Duloxetine Delayed-Release Capsules
Official ID D-0583-2026 ·
Official record ↗
See all Breckenridge Pharmaceutical recalls →
Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.